[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341063-105":59,"doc-detail-341063-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","viral-epitope-scanning-reveals-correlation-between-seasonal-hcovs-and-sars-cov-2-antibody-responses-among-cancer-and-non-cancer-patients","Viral Epitope Scanning Reveals Correlation between Seasonal HCoVs and SARS-CoV-2 Antibody Responses among Cancer and Non-Cancer Patients","","Seasonal coronaviruses (HCoVs) can generate cross-reactive antibodies against SARS-CoV-2, yet their influence on infection susceptibility and disease severity in cancer patients remains unclear. This study assessed prior HCoV infection effects on anti–SARS-CoV-2 antibody responses in COVID-19–asymptomatic cancer participants and non-cancer controls using VirScan with longitudinal plasma PhIP-seq. Although many individuals were anti–SARS-CoV-2 positive, most reported no COVID-19 history. Anti–SARS-CoV-2 magnitudes were lower in Kaposi sarcoma compared with other cancers and non-cancer groups. The HCoV antibody repertoire was comparable across cancer status, while anti-spike HCoV responses correlated strongly with anti–SARS-CoV-2 spike in cancer but only weakly in non-cancer, suggesting prior HCoV exposure may help limit SARS-CoV-2 infection and severity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/viral-epitope-scanning-reveals-correlation-between-seasonal-hcovs-and-sars-cov-2-antibody-responses-among-cancer-and-non-cancer-patients/341063/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/viral-epitope-scanning-reveals-correlation-between-seasonal-hcovs-and-sars-cov-2-antibody-responses-among-cancer-and-non-cancer-patients/341063.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How did the study measure antibody responses to SARS-CoV-2 and seasonal HCoVs?","Question",{"text":112,"@type":113},"The study used VirScan with phage immunoprecipitation and sequencing (PhIP-seq) on longitudinal plasma samples to profile high-resolution, epitope-level humoral responses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Did participants who were anti–SARS-CoV-2 positive report prior COVID-19?",{"text":117,"@type":113},"Despite testing positive for anti–SARS-CoV-2 antibodies, most participants were asymptomatic and had no prior history of a COVID-19 diagnosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationship did the study find between anti-spike HCoV and anti–SARS-CoV-2 responses?",{"text":121,"@type":113},"In cancer patients, magnitudes of anti-spike HCoV responses showed a strong positive association with anti–SARS-CoV-2 spike responses, while only a weak association was observed in non-cancer patients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341063,1790677725,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","viruses   \nArticle  \nViral Epitope Scanning Reveals Correlation between Seasonal HCoVs and SARS-CoV-2 Antibody Responses among Cancer and Non-Cancer Patients  \nSalum J. Lidenge 1,2,†, Dicle Yalcin 3,†, Sydney J. Bennett 3,4, Owen Ngalamika 5, Brenda B. Kweyamba 1, Chacha J. Mwita 1, For Yue Tso 3, Julius Mwaiselage 1,2, John T. West 3 and Charles Wood 3,4, *  \nCitation: Lidenge, S.J.; Yalcin, D.; Bennett, S.J.; Ngalamika, O.;  \nKweyamba, B.B.; Mwita, C.J.; Tso, F.Y.; Mwaiselage, J.; West, J.T.; Wood, C. Viral Epitope Scanning Reveals Correlation between Seasonal HCoVsand SARS-CoV-2 Antibody Responses among Cancer and Non-Cancer Patients. Viruses 2024, 16, 448 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)v16030448  \nAcademic Editors: Cynthia Derdeynand Irene Ramos-Lopez  \nReceived: 27 January 2024  \nRevised: 23 February 2024  \nAccepted: 9 March 2024  \nPublished: 13 March 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Clinical Research, Training, and Consultancy, Ocean Road Cancer Institute, Dar es Salaam P.O. Box 3592, Tanzania; [sjlidenge@yahoo.co.uk](sjlidenge@yahoo.co.uk) (S.J.L.); [bbashekera@yahoo.com](bbashekera@yahoo.com) (B.B.K.); [jmwaiselage@yahoo.com](jmwaiselage@yahoo.com) (J.M.)  \n2 Department of Clinical Oncology, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65001, Tanzania  \n3 Department of Interdisciplinary Oncology, Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA; [dyalci@lsuhsc.edu](dyalci@lsuhsc.edu) (D.Y.); [sydney.townsend14@huskers.unl.edu](sydney.townsend14@huskers.unl.edu) (S.J.B.); [ftso@lsuhsc.edu](ftso@lsuhsc.edu) (F.Y.T.); [jwest6@lsuhsc.edu](jwest6@lsuhsc.edu) (J.T.W.)  \n4 School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE 68516, USA  \n5 Dermatology and Venereology Division, University Teaching Hospital, University of Zambia School of Medicine, Lusaka P.O. Box 50001, Zambia; [owen_ngalamika@yahoo.com](owen_ngalamika@yahoo.com)  \n* Correspondence: [cwoo12@lsuhsc.edu](cwoo12@lsuhsc.edu); Tel.: +1-(504)-210-2702 † These authors contributed equally to this work.  \nAbstract: Seasonal coronaviruses (HCoVs) are known to contribute to cross-reactive antibody (Ab) responses against SARS-CoV-2 . While these responses are predictable due to the high homology between SARS-CoV-2 and other CoVs, the impact of these responses on susceptibility to SARS-CoV-2 infection in cancer patients is unclear. To investigate the influence of prior HCoV infection on antiSARS-CoV-2 Ab responses among COVID-19 asymptomatic individuals with cancer and controls without cancers, we utilized the VirScan technology in which phage immunoprecipitation and sequencing (PhIP-seq) of longitudinal plasma samples was performed to investigate high-resolution (i.e., epitope level) humoral CoV responses. Despite testing positive for anti-SARS-CoV-2 Ab in the plasma, a majority of the participants were asymptomatic for COVID-19 with no prior history of COVID-19 diagnosis. Although the magnitudes of the anti-SARS-CoV-2 Ab responses were lower in individuals with Kaposi sarcoma (KS) compared to non-KS cancer individuals and those without cancer, the HCoV Ab repertoire was similar between individuals with and without cancer independent of age, sex, HIV status, and chemotherapy. The magnitudes of the anti-spike HCoV responses showed a strong positive association with those of the anti-SARS-CoV-2 spike in cancer patients, and only a weak association in non-cancer patients, suggesting that prior infection with HCoVs might play a role in limiting SARS-CoV-2 infection and C","cbCaimEKAeYr6AjY","https://ap.wps.com/l/cbCaimEKAeYr6AjY","pdf",1808348,16,"English","# Abstract\n# Introduction","[{\"question\":\"How did the study measure antibody responses to SARS-CoV-2 and seasonal HCoVs?\",\"answer\":\"The study used VirScan with phage immunoprecipitation and sequencing (PhIP-seq) on longitudinal plasma samples to profile high-resolution, epitope-level humoral responses.\"},{\"question\":\"Did participants who were anti–SARS-CoV-2 positive report prior COVID-19?\",\"answer\":\"Despite testing positive for anti–SARS-CoV-2 antibodies, most participants were asymptomatic and had no prior history of a COVID-19 diagnosis.\"},{\"question\":\"What relationship did the study find between anti-spike HCoV and anti–SARS-CoV-2 responses?\",\"answer\":\"In cancer patients, magnitudes of anti-spike HCoV responses showed a strong positive association with anti–SARS-CoV-2 spike responses, while only a weak association was observed in non-cancer patients.\"}]","Viral Epitope Scanning Reveals Correlation between Seasonal HCoVs and SARS-CoV-2 Antibody Responses among Cancer and Non-Cancer Patients | PDF",1790040123,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41416046cb8c72b1b76054a7e1ffa90d.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/def5ebb32d66de831ed8f8c9b1406889.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1351bcb20bea9fa3fbff32d28228ec4b.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/923e8c7cd593186ca9a1ebe8674e9fbc.webp",980,1385]